XML 34 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues
Cost and expenses:    
Depreciation 5,353 2,931
Research and development 1,477,877 508,042
General and administrative 4,092,996 1,659,796
Total costs and expenses 5,576,226 2,170,769
Operating loss (5,576,226) (2,170,769)
Interest income 10,006 11,923
Net loss $ (5,566,220) $ (2,158,846)
Net loss per share—basic and diluted (in dollars per share) $ (0.20) $ (0.14)
Weighted average number of common shares— basic and diluted (in shares) 27,952,742 15,335,772